In an interesting study Lundgren et al. characterizes the association between CCND1 amplification, Cyclin D1 protein levels, and breast cancer recurrence, in a large randomized cohort of ER-positive breast cancer postmenopausal patients, treated with endocrine therapy. This evidence concerns the gene CCND1 and breast cancer.